3 completed, 1 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Recruiting 1 |
Follow Fenfluramine: new trials by email Literature Review of Fenfluramine trials Research Report on Fenfluramine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Refractory Infantile Spasms With Fenfluramine Fenfluramine - Infantile Spasm | Phase 2 | Recruiting | Children's Hospital of Orange County | 10 | 2023-06-16 | 2026-04-15 |
| Fenfluramine in CDKL5 Deficiency Disorder (CDD) Fenfluramine Hydrochloride - CDD | Phase 2 | Completed | NYU Langone Health | 7 | 2019-10-29 | 2023-10-04 |
| Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy Fenfluramine - Epilepsy, Lennox Gastaut Syndrome | Phase 2 | Completed | KU Leuven | 13 | 2016-01-01 | 2026-10-20 |
| Cardiovascular System in Obesity: Effect of Treatment fenfluramine, phentermine - Heart Diseases, Obesity | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1983-05-01 | 2013-11-26 |
Epilepsy (1) · Heart Diseases (1) · Lennox Gastaut Syndrome (1) · Obesity (1) · Spasms, Infantile (1) · Vascular Diseases (1)
Children's Hospital of Orange County (1) · KU Leuven (1) · NYU Langone Health (1) · National Heart, Lung, and Blood Institute (NHLBI) (1)
United States (2) · Belgium (1)
Daniel Shrey, MD (1) · Lieven G Lagae, MD, PhD (1) · Orrin Devinsky, MD (1)
R01HL029188 (1)